Envue Medical insider reports 240,000 shares

Envue Medical, Inc. insider Christian Michael Glibert, a more than 10% owner, reports beneficial ownership of 240,000 shares of common stock held directly as of January 14, 2026.

Rhea-AI Filing Summary

Envue Medical, Inc. insider Christian Michael Glibert, a more than 10% owner, reports beneficial ownership of 240,000 shares of common stock held directly as of January 14, 2026. The company states there were 1,088,192 shares of common stock outstanding as of February 2026; this is a baseline figure, not the amount reported as owned.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Glibert Christian Michael

Role 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock, par value $0.001 per share	--	--	--

Holdings After Transaction: Common Stock, par value $0.001 per share — 240,000 shares (Direct)

Footnotes (1)

1. F1. The reporting person's ownership is based on 1,088,192 shares of common stock outstanding as of February 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Envue Medical (FEED) Form 3 disclose about insider holdings?

Form 3 shows Christian Michael Glibert, a more than 10% owner of Envue Medical, beneficially owns 240,000 common shares directly. This establishes his initial reported ownership position as of January 14, 2026 under Section 16 reporting rules.

Who is the reporting person on Envue Medical (FEED) Form 3?

The reporting person is Christian Michael Glibert, identified as a more than 10% owner of Envue Medical. He reports direct beneficial ownership of the shares, meaning the holdings are attributed to him personally rather than through an intermediate entity.

How many Envue Medical (FEED) shares does the insider report owning?

The insider reports beneficial ownership of 240,000 shares of Envue Medical common stock. These shares are listed as directly owned, providing investors with a clear baseline of his initial stake subject to ongoing Section 16 reporting requirements.

Does Envue Medical (FEED) Form 3 show any insider buy or sell transactions?

The Form 3 functions as an initial ownership report and does not detail specific buy or sell transactions. It instead discloses the insider’s existing direct beneficial ownership of 240,000 common shares as of the January 14, 2026 event date.

What share count baseline does Envue Medical (FEED) reference in the Form 3?

The filing states that the reporting person’s ownership is based on 1,088,192 shares of Envue Medical common stock outstanding as of February 2026. This figure provides a reference point for understanding overall share capitalization at that time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Glibert Christian Michael

(Last) (First) (Middle)

4001 GREEN HERON SPRING DRIVE

(Street)

CARPINTERIA CA 93013

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/14/2026

3. Issuer Name and Ticker or Trading Symbol
ENvue Medical, Inc. [ FEED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.001 per share	240,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person's ownership is based on 1,088,192 shares of common stock outstanding as of February 2026.

	/s/ Christian Michael Glibert	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.